Digital Health Global

MARCH 30, 2023

The FDA has announced several guidelines and plans to hold at least one public meeting on digital health technologies (DHTs) to be used in drug clinical trials by the end of the year. Drug development process questions the reliability and accuracy of DHT products. More details at [link]

Digital Health 167

Digital Health Health Technology Drug Development 167

Digital Health Global

MARCH 26, 2024

BASEL, Switzerland–(BUSINESS WIRE)–Indivi, a leading MedTech company headquartered in Basel, Switzerland, has entered into an agreement with Biogen to advance digital health technology and develop digital biomarkers for Parkinson’s disease.

Health Technology 88

Health Technology Digital Health BioTech Drug Development 88

Digital Health Global

APRIL 5, 2024

The global pharmaceutical research and development (R&D) pipeline accounts for more than 21,000 molecules, as of April 2023, indicating a 5.8% hike over 2022, with more than 6,100 molecules in active development. In general, however, the pharma/biopharma industry has stagnated with respect to R&D activity.

Drug Development 88

Drug Development Pharmaceuticals Digital Health Health Technology 88

Digital Health Global

JUNE 13, 2023

“The utilization of evidence-based digital biomarkers is the key to transforming healthcare,” said Chris Benko, CEO, Koneksa. “We’re We’re on a mission to revolutionize drug development in clinical trials by harnessing the power of our digital solutions with real-time, data-driven insights.

Drug Development 88

Drug Development eMed BioTech Digital Health 88

Digital Health Global

NOVEMBER 30, 2023

Digital Health Technologies ( DHTs ) have revolutionized the landscape of clinical trials, particularly in neurology research, by enabling the collection of real-world data outside traditional clinical settings. It has been used in various studies in Europe with great results.

Health Technology 157

Health Technology Digital Health Life Science BioTech 157

Digital Health Global

NOVEMBER 20, 2023

–(BUSINESS WIRE)–AstraZeneca today launches Evinova, set to be a leading provider of digital health solutions to better meet the needs of healthcare professionals, regulators and patients. in 2060.

Life Science 88

Life Science Digital Health Drug Development Patient Experience 88

The Digital Health Corner

MARCH 26, 2018

In this scenario, a patient can digitally determine who should have access to the medical record (and which portion), which person(s) or entities saw or modified the record (and what portion) and when. Herding a patient’s data from many sources into a single record has always been a lofty goal of digital health.

Digital Health 117

Digital Health Interoperability Life Science Healthcare Data Security 117